Earnings Performance - ReWalk Robotics reported a quarterly loss of $0.50 per share, beating the Zacks Consensus Estimate of a loss of $0.53, representing an earnings surprise of 5.66% [1][2] - The company's loss per share increased from $0.35 a year ago [1] - ReWalk has surpassed consensus EPS estimates three times over the last four quarters [2] Revenue Performance - ReWalk posted revenues of $6.71 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 0.05% [3] - Year-over-year revenue increased significantly from $1.34 million [3] - The company has topped consensus revenue estimates only once in the last four quarters [3] Stock Performance - ReWalk shares have lost about 41.8% since the beginning of the year, underperforming the S&P 500's gain of 13.9% [4] - The stock's immediate price movement will depend on management's commentary on the earnings call [4] Future Outlook - The current consensus EPS estimate is -$0.41 on $8.31 million in revenues for the coming quarter [8] - For the current fiscal year, the consensus EPS estimate is -$1.94 on $30.82 million in revenues [8] - The estimate revisions trend for ReWalk is mixed, resulting in a Zacks Rank 3 (Hold) [7] Industry Context - ReWalk belongs to the Zacks Medical - Instruments industry, which is currently in the top 34% of Zacks industries [9] - The top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [9] Peer Comparison - Premier, Inc, another company in the Zacks Medical sector, is expected to report quarterly earnings of $0.49 per share, representing a year-over-year change of -27.9% [10] - Premier, Inc's revenues are expected to be $311.82 million, down 8.4% from the year-ago quarter [11]
ReWalk Robotics (LFWD) Reports Q2 Loss, Lags Revenue Estimates